Company Filing History:
5 out of 21 
2 out of 40 
1 out of 136 
Years Active: 1987-1998
Title: Robert T. White: Innovator in Respiratory Treatment Technologies
Introduction
Robert T. White, located in Fremont, CA, is an accomplished inventor with a significant portfolio comprising eight patents. His work primarily focuses on developing recombinant materials that play a crucial role in treating respiratory deficiency syndromes. His innovative contributions have advanced the field of pulmonary medicine significantly.
Latest Patents
Among his notable inventions, Robert T. White's latest patents include groundbreaking methods related to recombinant alveolar surfactant proteins. These patents detail the production of low molecular weight hydrophobic lung surfactant proteins derived from human and canine sources, which have apparent molecular weights of approximately 5 kD. These proteins can form dimers under specific conditions, allowing mass production through recombinant techniques. The availability of these proteins enables their use in pharmaceutical compositions aimed at alleviating respiratory disorders. Furthermore, he has disclosed complete coding and amino acid sequences for both canine and human 32K alveolar surfactant proteins. This work also includes methods for purifying these proteins, leveraging their carbohydrate affinity for enhanced efficacy in treatments.
Career Highlights
Robert T. White has made significant strides in his career, working with prominent companies like California Biotechnology Inc. and Scios Nova, Inc. His experiences in these organizations have allowed him to refine his expertise and drive innovation within the industry.
Collaborations
Throughout his career, Robert has collaborated with esteemed colleagues such as James W. Schilling, Jr. and Bradley J. Benson. These partnerships have fostered an environment that promotes pioneering research and development in the field of respiratory treatment.
Conclusion
Robert T. White's innovative work in recombinant alveolar surfactant proteins exemplifies the potential of targeted research in improving healthcare outcomes. His eight patents not only reflect his dedication to innovation but also demonstrate the vital role that collaboration and industry experience play in advancing medical treatments for respiratory deficiencies.